Related Experiment Video
Updated: Aug 12, 2025

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
Published on: December 27, 2010
VIDAS3® TB-IGRA assay: evaluation of performance characteristics in a predominantly low risk, low incidence
Annelies De Bel1, Annelies Brouwers2, Frederick Verbeke1
1Clinical laboratory, General Hospital Groeninge, Kortrijk, Belgium.
Objectives:
To evaluate the analytical performance of the TB-IGRA® assay on the VIDAS3 platform (bioMérieux) when testing a predominantly low risk population in a low incidence area.
Results:
Eighty-eight percent of the results were concordant between QuantiFERON®-TB Gold-Plus (QFT®-Plus, QIAGEN) and TB-IGRA®. All 12 of 99 (12.1%) discordant results were determined positive only with the TB-IGRA® assay. In 11 of 12 of these discordant cases, no explanation could be found in the medical record. Five of these discrepant results were probably caused by the use of contaminated stimulation reagents. The remaining 6 discrepant samples were also part of the reproducibility experiment and only 2 results were reproducible positive. Overall, in the reproducibility experiment 5 of 25 (20.0 %) results were not repeatable.
Conclusions:
the TB-IGRA® assay seems prone to contamination. Besides, we documented a reproducibility of only 80.0% with the TB-IGRA® assay.
Related Concept Videos
Relative Risk
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...

